Opioid sparing in cleft palate surgery

Logan Carr, Megan Gray, Brad Morrow, Morgan Brgoch, Donald Mackay, Thomas Samson

Research output: Contribution to journalArticle

Abstract

Objective: This study aimed to determine whether intraoperative acetaminophen was able to decrease opioid consumption, pain scores, and length of stay while increasing oral intake in cleft palate surgery. Design/Setting/Patients: One hundred consecutive patients with cleft palate who underwent a von Langenbeck or 2-flap palatoplasty and intravelar veloplasty at a tertiary medical center by the 2 senior authors from 2010 to 2015 were reviewed. Interventions: Three intraoperative treatment groups were analyzed: intravenous (IV) acetaminophen, per rectal (PR) acetaminophen, and no acetaminophen. All patients received long-acting local anesthesia infiltration before incision. Additionally, all patients were admitted overnight and given weight-based per oral (PO) acetaminophen and oxycodone and IV morphine as needed based on pain scores. Outcomes Measured: The study outcomes included pain scores, opioid requirement, length of stay, and oral intake. Results: The treatment groups were comprised of 40 patients who received IV acetaminophen, 22 PR acetaminophen, and 35 none. Concerning demographic data, there was no statistical difference between treatment groups. There was no statistically significant difference for opioid intake, although both IV and PR acetaminophen groups had decreased pain scores (P =.029). There was no difference in oral intake (P =.13) or length of stay (P =.31) between treatment groups. Conclusion: In this study, intraoperative administration of acetaminophen was associated with decreased pain scores, but no opioid-sparing effect. As other studies have shown an opioid-sparing effect with postoperative acetaminophen, we recommend withholding the intraoperative dose and beginning therapy in the immediate postoperative period.

Original languageEnglish (US)
Pages (from-to)1200-1204
Number of pages5
JournalCleft Palate-Craniofacial Journal
Volume55
Issue number9
DOIs
StatePublished - Jan 1 2018

Fingerprint

Cleft Palate
Acetaminophen
Opioid Analgesics
Pain
Length of Stay
Senior Centers
Therapeutics
Local Anesthesia
Postoperative Period
Morphine
Demography
Outcome Assessment (Health Care)
Weights and Measures

All Science Journal Classification (ASJC) codes

  • Oral Surgery
  • Otorhinolaryngology

Cite this

Carr, Logan ; Gray, Megan ; Morrow, Brad ; Brgoch, Morgan ; Mackay, Donald ; Samson, Thomas. / Opioid sparing in cleft palate surgery. In: Cleft Palate-Craniofacial Journal. 2018 ; Vol. 55, No. 9. pp. 1200-1204.
@article{37caa9f9faf14b899dc9be1a0d61f322,
title = "Opioid sparing in cleft palate surgery",
abstract = "Objective: This study aimed to determine whether intraoperative acetaminophen was able to decrease opioid consumption, pain scores, and length of stay while increasing oral intake in cleft palate surgery. Design/Setting/Patients: One hundred consecutive patients with cleft palate who underwent a von Langenbeck or 2-flap palatoplasty and intravelar veloplasty at a tertiary medical center by the 2 senior authors from 2010 to 2015 were reviewed. Interventions: Three intraoperative treatment groups were analyzed: intravenous (IV) acetaminophen, per rectal (PR) acetaminophen, and no acetaminophen. All patients received long-acting local anesthesia infiltration before incision. Additionally, all patients were admitted overnight and given weight-based per oral (PO) acetaminophen and oxycodone and IV morphine as needed based on pain scores. Outcomes Measured: The study outcomes included pain scores, opioid requirement, length of stay, and oral intake. Results: The treatment groups were comprised of 40 patients who received IV acetaminophen, 22 PR acetaminophen, and 35 none. Concerning demographic data, there was no statistical difference between treatment groups. There was no statistically significant difference for opioid intake, although both IV and PR acetaminophen groups had decreased pain scores (P =.029). There was no difference in oral intake (P =.13) or length of stay (P =.31) between treatment groups. Conclusion: In this study, intraoperative administration of acetaminophen was associated with decreased pain scores, but no opioid-sparing effect. As other studies have shown an opioid-sparing effect with postoperative acetaminophen, we recommend withholding the intraoperative dose and beginning therapy in the immediate postoperative period.",
author = "Logan Carr and Megan Gray and Brad Morrow and Morgan Brgoch and Donald Mackay and Thomas Samson",
year = "2018",
month = "1",
day = "1",
doi = "10.1177/1055665618764516",
language = "English (US)",
volume = "55",
pages = "1200--1204",
journal = "Cleft Palate-Craniofacial Journal",
issn = "1055-6656",
publisher = "American Cleft Palate Craniofacial Association",
number = "9",

}

Opioid sparing in cleft palate surgery. / Carr, Logan; Gray, Megan; Morrow, Brad; Brgoch, Morgan; Mackay, Donald; Samson, Thomas.

In: Cleft Palate-Craniofacial Journal, Vol. 55, No. 9, 01.01.2018, p. 1200-1204.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Opioid sparing in cleft palate surgery

AU - Carr, Logan

AU - Gray, Megan

AU - Morrow, Brad

AU - Brgoch, Morgan

AU - Mackay, Donald

AU - Samson, Thomas

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: This study aimed to determine whether intraoperative acetaminophen was able to decrease opioid consumption, pain scores, and length of stay while increasing oral intake in cleft palate surgery. Design/Setting/Patients: One hundred consecutive patients with cleft palate who underwent a von Langenbeck or 2-flap palatoplasty and intravelar veloplasty at a tertiary medical center by the 2 senior authors from 2010 to 2015 were reviewed. Interventions: Three intraoperative treatment groups were analyzed: intravenous (IV) acetaminophen, per rectal (PR) acetaminophen, and no acetaminophen. All patients received long-acting local anesthesia infiltration before incision. Additionally, all patients were admitted overnight and given weight-based per oral (PO) acetaminophen and oxycodone and IV morphine as needed based on pain scores. Outcomes Measured: The study outcomes included pain scores, opioid requirement, length of stay, and oral intake. Results: The treatment groups were comprised of 40 patients who received IV acetaminophen, 22 PR acetaminophen, and 35 none. Concerning demographic data, there was no statistical difference between treatment groups. There was no statistically significant difference for opioid intake, although both IV and PR acetaminophen groups had decreased pain scores (P =.029). There was no difference in oral intake (P =.13) or length of stay (P =.31) between treatment groups. Conclusion: In this study, intraoperative administration of acetaminophen was associated with decreased pain scores, but no opioid-sparing effect. As other studies have shown an opioid-sparing effect with postoperative acetaminophen, we recommend withholding the intraoperative dose and beginning therapy in the immediate postoperative period.

AB - Objective: This study aimed to determine whether intraoperative acetaminophen was able to decrease opioid consumption, pain scores, and length of stay while increasing oral intake in cleft palate surgery. Design/Setting/Patients: One hundred consecutive patients with cleft palate who underwent a von Langenbeck or 2-flap palatoplasty and intravelar veloplasty at a tertiary medical center by the 2 senior authors from 2010 to 2015 were reviewed. Interventions: Three intraoperative treatment groups were analyzed: intravenous (IV) acetaminophen, per rectal (PR) acetaminophen, and no acetaminophen. All patients received long-acting local anesthesia infiltration before incision. Additionally, all patients were admitted overnight and given weight-based per oral (PO) acetaminophen and oxycodone and IV morphine as needed based on pain scores. Outcomes Measured: The study outcomes included pain scores, opioid requirement, length of stay, and oral intake. Results: The treatment groups were comprised of 40 patients who received IV acetaminophen, 22 PR acetaminophen, and 35 none. Concerning demographic data, there was no statistical difference between treatment groups. There was no statistically significant difference for opioid intake, although both IV and PR acetaminophen groups had decreased pain scores (P =.029). There was no difference in oral intake (P =.13) or length of stay (P =.31) between treatment groups. Conclusion: In this study, intraoperative administration of acetaminophen was associated with decreased pain scores, but no opioid-sparing effect. As other studies have shown an opioid-sparing effect with postoperative acetaminophen, we recommend withholding the intraoperative dose and beginning therapy in the immediate postoperative period.

UR - http://www.scopus.com/inward/record.url?scp=85063530733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063530733&partnerID=8YFLogxK

U2 - 10.1177/1055665618764516

DO - 10.1177/1055665618764516

M3 - Article

C2 - 29578803

AN - SCOPUS:85063530733

VL - 55

SP - 1200

EP - 1204

JO - Cleft Palate-Craniofacial Journal

JF - Cleft Palate-Craniofacial Journal

SN - 1055-6656

IS - 9

ER -